SEVERE HYPOFIBRINOGENEMIA IN A PATIENT WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB: CASE-BASED REVIEW

The Giant cell arteritis (GCA) is the most common form of systemic vasculitis in elderly patients. The treatment includes high doses of steroids and interleukin (IL)-6 inhibitor tocilizumab, especially in refractory or relapsing disease or in cases where there is an increased risk of steroid-related...

Full description

Bibliographic Details

Published in:	Anti-Aging Eastern Europe
Main Authors:	Željka Kardum, Ana Šimac, Kristina Frketić Marović, Ana Marija Masle, Jasminka MIlas Ahić
Format:	Article
Language:	English
Published:	Edeme Resort Medical & Spa 2023-12-01
Subjects:	giant cell arteritis il-6 inhibitor tocilizumab thrombocytopenia hypofibrinogenemia fxiii deficiency
Online Access:	https://antiagingeeu.com/index.php/journal/article/view/71